Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-02-20 @ 9:47 AM
Study NCT ID:
NCT03377556
Status:
COMPLETED
Last Update Posted:
2021-06-23
First Post:
2017-12-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer
Sponsor:
SWOG Cancer Research Network
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | ATM Gene Mutation | View |
| None | ATR Gene Mutation | View |
| None | BARD1 Gene Mutation | View |
| None | BRCA1 Gene Mutation | View |
| None | BRCA2 Gene Mutation | View |
| None | BRIP1 Gene Mutation | View |
| None | CHEK1 Gene Mutation | View |
| None | CHEK2 Gene Mutation | View |
| None | FANCA Gene Mutation | View |
| None | FANCC Gene Mutation | View |
| None | FANCD2 Gene Mutation | View |
| None | FANCF Gene Mutation | View |
| None | FANCM Gene Mutation | View |
| None | NBN Gene Mutation | View |
| None | PALB2 Gene Mutation | View |
| None | RAD51 Gene Mutation | View |
| None | RAD51B Gene Mutation | View |
| None | RAD54L Gene Mutation | View |
| None | Recurrent Squamous Cell Lung Carcinoma | View |
| None | RPA1 Gene Mutation | View |
| None | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | View |
Keywords: